Essential Practices for HRSA Audit Preparedness

SPONSORED CONTENT

The Health Resources and Services Administration (HRSA) conducts randomized audits to assess compliance with the 340B drug pricing program, a federal initiative aimed at providing discounted medications to eligible entities. With more than 13,100 parent entities participating in 340B, this increased participation comes with the responsibility of increased oversight and the

Read More »

Prepping for HRSA Audits

SPONSORED CONTENT

Are you truly ready for a HRSA audit? Today we have two 340B experts, Dennis Killian and Heather Erickson, from CPS Solutions, LLC. (CPS) here to discuss three topics that will help you prepare. CPS has managed 340B Programs for hospitals and health systems since the program’s inception, ensuring compliance with the 340B statute, HRSA guidance,

Read More »

Bridging the primary care gap: The role of in-house pharmacies in today’s healthcare marketplace

Holly Russo, Maxor 340B

SPONSORED CONTENT

Healthcare leaders have a lot on their plates. Today’s healthcare landscape requires health care organizations to compete in attracting and retaining qualified employees, remain up to date on reimbursement changes, select and employ technologies to serve more patients in convenient ways, and adhere to quality standards to serve their communities.

With

Read More »

340B REPORT SPONSOR SPOTLIGHT

RxStrategies

Q: Tell us some interesting details about your company’s history.

Imagine a world where flip phones were the pinnacle of consumer technology – that’s the era when RxStrategies was founded.

Read More »

Unlocking the Value of 340B Consultants: Their Roles and Responsibilities

SPONSORED CONTENT

In the complex landscape of healthcare, the 340B program plays a vital role in ensuring that vulnerable patients with limited financial resources have access to affordable medications. It enables qualified covered entities to maximize their resources and offer a wider range of benefits and services to those in need.

Managing this program efficiently and

Read More »

340B Webinar—State of 340B in 2024: Biggest Developments Expected this Year

SPONSORED CONTENT

Join our webinar for a comprehensive exploration of the current status of the 340B program, featuring a review of major industry trends from 2023 and key developments anticipated for 2024.
We’ll discuss what entities should expect and prepare for in the upcoming year, addressing crucial questions about manufacturer restrictions and potential Congressional actions.

Read More »

Visante’s Top 10 Issues Facing Health System Pharmacy for 2024

SPONSORED CONTENT

 In 2024, pharmacy will play an even more significant and critical role in health systems’ financial and operational performance nationwide. While health systems face daunting challenges, increasing risks, and suffocating regulatory and compliance burdens, high-performing pharmacy organizations are poised to mitigate financial losses and improve operations. We’ve

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report